ChAd155-vectored respiratory syncytial virus (RSV) investigational vaccine (ChAd155-RSV) is immunogenic when administered at different dose levels in infants aged 6–7 months

Anderson E., Baquero Artigao F., D Boucher F., Campbell J. D., Castelli Gattinara G., ÇETİN B. Ş., ...More

39th Annual Meeting of the European Society of Paediatric Infectious Diseases (ESPID)., Cenevre, Switzerland, 24 - 29 May 2021, (Full Text)

  • Publication Type: Conference Paper / Full Text
  • City: Cenevre
  • Country: Switzerland
  • Dokuz Eylül University Affiliated: Yes